The global AI-driven Drug Discovery market size is predicted to grow from US$ 884 million in 2025 to US$ 1643 million in 2031; it is expected to grow at a CAGR of 10.9% from 2025 to 2031.
AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淎I-driven Drug Discovery Industry Forecast鈥� looks at past sales and reviews total world AI-driven Drug Discovery sales in 2024, providing a comprehensive analysis by region and market sector of projected AI-driven Drug Discovery sales for 2025 through 2031. With AI-driven Drug Discovery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI-driven Drug Discovery industry.
This Insight Report provides a comprehensive analysis of the global AI-driven Drug Discovery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI-driven Drug Discovery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global AI-driven Drug Discovery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI-driven Drug Discovery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI-driven Drug Discovery.
This report presents a comprehensive overview, market shares, and growth opportunities of AI-driven Drug Discovery market by product type, application, key players and key regions and countries.
Segmentation by Type:
Small Molecule Drug
Biological Modeling
Structural Biology
Others
Segmentation by Application:
Pharmaceutical and Biotechnology Companies
Research Laboratories
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Entos
Selvita
Benevolent
Exscientia
Euretos
Illumina with AstraZeneca
Novo Nordisk with Microsoft
Iktos
Aqemia
Zephyr AI
Cyclicarx
Eli Lilly
Terray Therapeutics
Ardigen
ReviveMed
Insilico Medicine
XtalPi
MindRank
DP Technology
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global AI-driven Drug Discovery Market Size (2020-2031)
2.1.2 AI-driven Drug Discovery Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for AI-driven Drug Discovery by Country/Region (2020, 2024 & 2031)
2.2 AI-driven Drug Discovery Segment by Type
2.2.1 Small Molecule Drug
2.2.2 Biological Modeling
2.2.3 Structural Biology
2.2.4 Others
2.3 AI-driven Drug Discovery Market Size by Type
2.3.1 AI-driven Drug Discovery Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global AI-driven Drug Discovery Market Size Market Share by Type (2020-2025)
2.4 AI-driven Drug Discovery Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 Research Laboratories
2.5 AI-driven Drug Discovery Market Size by Application
2.5.1 AI-driven Drug Discovery Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global AI-driven Drug Discovery Market Size Market Share by Application (2020-2025)
3 AI-driven Drug Discovery Market Size by Player
3.1 AI-driven Drug Discovery Market Size Market Share by Player
3.1.1 Global AI-driven Drug Discovery Revenue by Player (2020-2025)
3.1.2 Global AI-driven Drug Discovery Revenue Market Share by Player (2020-2025)
3.2 Global AI-driven Drug Discovery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI-driven Drug Discovery by Region
4.1 AI-driven Drug Discovery Market Size by Region (2020-2025)
4.2 Global AI-driven Drug Discovery Annual Revenue by Country/Region (2020-2025)
4.3 Americas AI-driven Drug Discovery Market Size Growth (2020-2025)
4.4 APAC AI-driven Drug Discovery Market Size Growth (2020-2025)
4.5 Europe AI-driven Drug Discovery Market Size Growth (2020-2025)
4.6 Middle East & Africa AI-driven Drug Discovery Market Size Growth (2020-2025)
5 Americas
5.1 Americas AI-driven Drug Discovery Market Size by Country (2020-2025)
5.2 Americas AI-driven Drug Discovery Market Size by Type (2020-2025)
5.3 Americas AI-driven Drug Discovery Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI-driven Drug Discovery Market Size by Region (2020-2025)
6.2 APAC AI-driven Drug Discovery Market Size by Type (2020-2025)
6.3 APAC AI-driven Drug Discovery Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe AI-driven Drug Discovery Market Size by Country (2020-2025)
7.2 Europe AI-driven Drug Discovery Market Size by Type (2020-2025)
7.3 Europe AI-driven Drug Discovery Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AI-driven Drug Discovery by Region (2020-2025)
8.2 Middle East & Africa AI-driven Drug Discovery Market Size by Type (2020-2025)
8.3 Middle East & Africa AI-driven Drug Discovery Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global AI-driven Drug Discovery Market Forecast
10.1 Global AI-driven Drug Discovery Forecast by Region (2026-2031)
10.1.1 Global AI-driven Drug Discovery Forecast by Region (2026-2031)
10.1.2 Americas AI-driven Drug Discovery Forecast
10.1.3 APAC AI-driven Drug Discovery Forecast
10.1.4 Europe AI-driven Drug Discovery Forecast
10.1.5 Middle East & Africa AI-driven Drug Discovery Forecast
10.2 Americas AI-driven Drug Discovery Forecast by Country (2026-2031)
10.2.1 United States Market AI-driven Drug Discovery Forecast
10.2.2 Canada Market AI-driven Drug Discovery Forecast
10.2.3 Mexico Market AI-driven Drug Discovery Forecast
10.2.4 Brazil Market AI-driven Drug Discovery Forecast
10.3 APAC AI-driven Drug Discovery Forecast by Region (2026-2031)
10.3.1 China AI-driven Drug Discovery Market Forecast
10.3.2 Japan Market AI-driven Drug Discovery Forecast
10.3.3 Korea Market AI-driven Drug Discovery Forecast
10.3.4 Southeast Asia Market AI-driven Drug Discovery Forecast
10.3.5 India Market AI-driven Drug Discovery Forecast
10.3.6 Australia Market AI-driven Drug Discovery Forecast
10.4 Europe AI-driven Drug Discovery Forecast by Country (2026-2031)
10.4.1 Germany Market AI-driven Drug Discovery Forecast
10.4.2 France Market AI-driven Drug Discovery Forecast
10.4.3 UK Market AI-driven Drug Discovery Forecast
10.4.4 Italy Market AI-driven Drug Discovery Forecast
10.4.5 Russia Market AI-driven Drug Discovery Forecast
10.5 Middle East & Africa AI-driven Drug Discovery Forecast by Region (2026-2031)
10.5.1 Egypt Market AI-driven Drug Discovery Forecast
10.5.2 South Africa Market AI-driven Drug Discovery Forecast
10.5.3 Israel Market AI-driven Drug Discovery Forecast
10.5.4 Turkey Market AI-driven Drug Discovery Forecast
10.6 Global AI-driven Drug Discovery Forecast by Type (2026-2031)
10.7 Global AI-driven Drug Discovery Forecast by Application (2026-2031)
10.7.1 GCC Countries Market AI-driven Drug Discovery Forecast
11 Key Players Analysis
11.1 Entos
11.1.1 Entos Company Information
11.1.2 Entos AI-driven Drug Discovery Product Offered
11.1.3 Entos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Entos Main Business Overview
11.1.5 Entos Latest Developments
11.2 Selvita
11.2.1 Selvita Company Information
11.2.2 Selvita AI-driven Drug Discovery Product Offered
11.2.3 Selvita AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Selvita Main Business Overview
11.2.5 Selvita Latest Developments
11.3 Benevolent
11.3.1 Benevolent Company Information
11.3.2 Benevolent AI-driven Drug Discovery Product Offered
11.3.3 Benevolent AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Benevolent Main Business Overview
11.3.5 Benevolent Latest Developments
11.4 Exscientia
11.4.1 Exscientia Company Information
11.4.2 Exscientia AI-driven Drug Discovery Product Offered
11.4.3 Exscientia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Exscientia Main Business Overview
11.4.5 Exscientia Latest Developments
11.5 Euretos
11.5.1 Euretos Company Information
11.5.2 Euretos AI-driven Drug Discovery Product Offered
11.5.3 Euretos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Euretos Main Business Overview
11.5.5 Euretos Latest Developments
11.6 Illumina with AstraZeneca
11.6.1 Illumina with AstraZeneca Company Information
11.6.2 Illumina with AstraZeneca AI-driven Drug Discovery Product Offered
11.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Illumina with AstraZeneca Main Business Overview
11.6.5 Illumina with AstraZeneca Latest Developments
11.7 Novo Nordisk with Microsoft
11.7.1 Novo Nordisk with Microsoft Company Information
11.7.2 Novo Nordisk with Microsoft AI-driven Drug Discovery Product Offered
11.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Novo Nordisk with Microsoft Main Business Overview
11.7.5 Novo Nordisk with Microsoft Latest Developments
11.8 Iktos
11.8.1 Iktos Company Information
11.8.2 Iktos AI-driven Drug Discovery Product Offered
11.8.3 Iktos AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Iktos Main Business Overview
11.8.5 Iktos Latest Developments
11.9 Aqemia
11.9.1 Aqemia Company Information
11.9.2 Aqemia AI-driven Drug Discovery Product Offered
11.9.3 Aqemia AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Aqemia Main Business Overview
11.9.5 Aqemia Latest Developments
11.10 Zephyr AI
11.10.1 Zephyr AI Company Information
11.10.2 Zephyr AI AI-driven Drug Discovery Product Offered
11.10.3 Zephyr AI AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Zephyr AI Main Business Overview
11.10.5 Zephyr AI Latest Developments
11.11 Cyclicarx
11.11.1 Cyclicarx Company Information
11.11.2 Cyclicarx AI-driven Drug Discovery Product Offered
11.11.3 Cyclicarx AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Cyclicarx Main Business Overview
11.11.5 Cyclicarx Latest Developments
11.12 Eli Lilly
11.12.1 Eli Lilly Company Information
11.12.2 Eli Lilly AI-driven Drug Discovery Product Offered
11.12.3 Eli Lilly AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Eli Lilly Main Business Overview
11.12.5 Eli Lilly Latest Developments
11.13 Terray Therapeutics
11.13.1 Terray Therapeutics Company Information
11.13.2 Terray Therapeutics AI-driven Drug Discovery Product Offered
11.13.3 Terray Therapeutics AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Terray Therapeutics Main Business Overview
11.13.5 Terray Therapeutics Latest Developments
11.14 Ardigen
11.14.1 Ardigen Company Information
11.14.2 Ardigen AI-driven Drug Discovery Product Offered
11.14.3 Ardigen AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Ardigen Main Business Overview
11.14.5 Ardigen Latest Developments
11.15 ReviveMed
11.15.1 ReviveMed Company Information
11.15.2 ReviveMed AI-driven Drug Discovery Product Offered
11.15.3 ReviveMed AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 ReviveMed Main Business Overview
11.15.5 ReviveMed Latest Developments
11.16 Insilico Medicine
11.16.1 Insilico Medicine Company Information
11.16.2 Insilico Medicine AI-driven Drug Discovery Product Offered
11.16.3 Insilico Medicine AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Insilico Medicine Main Business Overview
11.16.5 Insilico Medicine Latest Developments
11.17 XtalPi
11.17.1 XtalPi Company Information
11.17.2 XtalPi AI-driven Drug Discovery Product Offered
11.17.3 XtalPi AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 XtalPi Main Business Overview
11.17.5 XtalPi Latest Developments
11.18 MindRank
11.18.1 MindRank Company Information
11.18.2 MindRank AI-driven Drug Discovery Product Offered
11.18.3 MindRank AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 MindRank Main Business Overview
11.18.5 MindRank Latest Developments
11.19 DP Technology
11.19.1 DP Technology Company Information
11.19.2 DP Technology AI-driven Drug Discovery Product Offered
11.19.3 DP Technology AI-driven Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 DP Technology Main Business Overview
11.19.5 DP Technology Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
